Financials
Financial year 2025
Gross margin
€ 26.8 million
▲ 3615% vs 2024
Profit
Growing€ 7.7 million
▲ 212% vs 2024
Debts
Low€ 4.1 million
▲ 46% vs 2024
EsoBiotec from Mont-Saint-Guibert, company number BE0756885159, closed financial year 2025 with a result of € 7.7 million after tax. For that financial year EsoBiotec recorded a gross margin of € 26.8 million and equity of € 12.4 million. Compared with financial year 2024, the result moved from € -6.9 million to € 7.7 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
What happened at EsoBiotec?
What happened at EsoBiotec in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- CARSTEN LINNEMANN stepped down as director. NBB
- ANGELA THOMPSON stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 7.7 million. Source: NBB ↗
- JEAN-PIERRE LATERE DWAN'ISA stepped down as director. NBB
- CARSTEN LINNEMANN became a director. NBB
- ANGELA THOMPSON became a director. NBB
- JEAN-PIERRE LATERE DWAN'ISA became a director. NBB
- New establishment in Mont-Saint-Guibert. KBO
In short
From € 198,317 loss in 2021 to € 7.7 million profit in 2025.
Paid € 4.1 million in corporate taxes since 2021.
Best year ever: 2025, with € 7.7 million profit.
On average € 2.8 million of value added per employee in 2025.
A new publication or filing at EsoBiotec? We notify you, reason included.
Follow EsoBiotecNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Neogene Therapeutics (100%).
Directors
According to the 2025 annual accounts
CARSTEN LINNEMANN
Director
since 2025 · until 2031
since 2024 · until 2026
ANGELA THOMPSON
Director
since 2025 · until 2031
Shareholders
Neogene Therapeutics
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue André Dumont 5
1435 Mont-Saint-Guibert
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Details
- Company number
- 0756.885.159
- VAT number
- BE 0756.885.159
- Registered office
- Rue André Dumont 5, 1435 Mont-Saint-Guibert
- Names & denominations
- EsoBiotec
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 October 2020
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied